These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3056254)

  • 1. Monitoring beta-lactamase activity in vivo by 13C nuclear magnetic resonance spectroscopy.
    Mobashery S; Lerner SA; Johnston M
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1196-203. PubMed ID: 3056254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactions of Escherichia coli TEM beta-lactamase with cephalothin and with C10-dipeptidyl cephalosporin esters.
    Mobashery S; Johnston M
    J Biol Chem; 1986 Jun; 261(17):7879-87. PubMed ID: 3519615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of alanine racemase by beta-chloro-L-alanine released enzymatically from amino acid and peptide C10-esters of deacetylcephalothin.
    Mobashery S; Johnston M
    Biochemistry; 1987 Sep; 26(18):5878-84. PubMed ID: 3118951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-(D,L-alpha-fluoro-2-thienylacetamido)cephalosporanic acid (L 14655), a new semisynthetic cephalosporin. Synthesis and preliminary biological evaluation.
    Malabarba A; Somma S; Berti M; Cavalleri B
    Farmaco Sci; 1984 Dec; 39(12):1050-60. PubMed ID: 6335695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
    Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J; Aguilar C; Ayala G; Estrada MA; Garza-Ramos U; Lara-Lemus R; Ledezma L
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
    Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of residue Lys315 in the mechanism of action of the Enterobacter cloacae 908R beta-lactamase.
    Monnaie D; Dubus A; Cooke D; Marchand-Brynaert J; Normark S; Frère JM
    Biochemistry; 1994 May; 33(17):5193-201. PubMed ID: 8172894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
    Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
    Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to penicillins and cephalosporins in beta-lactamase producing strains of E. coli and relative amount of beta-lactamase produced from these strains.
    Normark S; Grundström T; Bergström S
    Scand J Infect Dis Suppl; 1980; suppl 25():23-9. PubMed ID: 7010537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.
    Bergström S; Normark S
    Antimicrob Agents Chemother; 1979 Oct; 16(4):427-33. PubMed ID: 391149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogenic redox assay for beta-lactamases yielding water-insoluble products. I. Kinetic behavior and redox chemistry.
    Bieniarz C; Young DF; Cornwell MJ
    Anal Biochem; 1992 Dec; 207(2):321-8. PubMed ID: 1481987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems encountered in the characterization of IRT beta-lactamase-producing clinical Escherichia coli isolates intermediate-resistant to cephalothin.
    Chaibi EB; Farzaneh S; Morand A; Peduzzi J; Barthelemy M; Sirot D; Labia R
    J Antimicrob Chemother; 1996 Jan; 37(1):190-1. PubMed ID: 8647764
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase.
    Alba J; Ishii Y; Thomson K; Moland ES; Yamaguchi K
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4760-2. PubMed ID: 16251324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes.
    Prinarakis EE; Tzouvelekis LS; Legakis NJ
    Chemotherapy; 1998; 44(4):260-4. PubMed ID: 9681202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
    Réjiba S; Kechrid A
    J Chemother; 2007 Aug; 19(4):382-7. PubMed ID: 17855181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
    Russell AD; Tottle PC
    Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.